Patents by Inventor Shyi-Tai M. Jan

Shyi-Tai M. Jan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7037937
    Abstract: Compounds are described that bind to tubulin causing tubulin depolymerization and inhibiting tubulin polymerization. The compounds of the invention are therapeutically effective to inhibit cellular proliferation, for example, as effective anti-cancer agents. The compounds can also induce cytotoxicity in cells such as leukemia cells. The chemical structure of the compounds includes a furan, thiophene, thiazole, oxazole, or imidazole group at one end of the molecule (head) and a hydrophobic, aliphatic chain at the other end of the molecule (tail).
    Type: Grant
    Filed: May 11, 2004
    Date of Patent: May 2, 2006
    Assignee: Parker Hughes Institute
    Inventors: Fatih M. Uckun, Shyi-Tai M. Jan
  • Publication number: 20040229935
    Abstract: Compounds are described that bind to tubulin causing tubulin depolymerization and inhibiting tubulin polymerization. The compounds of the invention are therapeutically effective to inhibit cellular proliferation, for example, as effective anti-cancer agents. The compounds can also induce cytotoxicity in cells such as leukemia cells. The chemical structure of the compounds includes a furan, thiophene, thiazole, oxazole, or imidazole group at one end of the molecule (head) and a hydrophobic, aliphatic chain at the other end of the molecule (tail).
    Type: Application
    Filed: May 11, 2004
    Publication date: November 18, 2004
    Applicant: Parker Hughes Institute
    Inventors: Fatih M. Uckun, Shyi-Tai M. Jan
  • Patent number: 6734207
    Abstract: Compounds are described that bind to tubulin causing tubulin depolymerization and inhibiting tubulin polymerization. The compounds of the invention are therapeutically effective to inhibit cellular proliferation, for example, as effective anti-cancer agents. The compounds can also induce cytotoxicity in cells such as leukemia cells. The chemical structure of the compounds includes a furan, thiophene, thiazole, oxazole, or imidazole group at one end of the molecule (head) and a hydrophobic, aliphatic chain at the other end of the molecule (tail).
    Type: Grant
    Filed: April 18, 2002
    Date of Patent: May 11, 2004
    Assignee: Parker Hughes Institute
    Inventors: Fatih M. Uckun, Shyi-Tai M. Jan
  • Publication number: 20030055100
    Abstract: Compounds are described that bind to tubulin causing tubulin depolymerization and inhibiting tubulin polymerization. The compounds of the invention are therapeutically effective to inhibit cellular proliferation, for example, as effective anti-cancer agents. The compounds can also induce cytotoxicity in cells such as leukemia cells. The chemical structure of the compounds includes a furan, thiophene, thiazole, oxazole, or imidazole group at one end of the molecule (head) and a hydrophobic, aliphatic chain at the other end of the molecule (tail).
    Type: Application
    Filed: April 18, 2002
    Publication date: March 20, 2003
    Inventors: Fatih M. Uckun, Shyi-Tai M. Jan
  • Patent number: 6329420
    Abstract: Novel tubulin binding compounds having potent tubulin depolymerization activity and inhibitory activity against tubulin polymerization. The compounds are effective agents for inhibiting cellular proliferation, for example, in cancer cells. The compounds are adapted to interact favorably with a novel tubulin binding pocket, which pocket is useful for screening of anti-tubulin, anti-proliferation, and anti-cancer drugs.
    Type: Grant
    Filed: May 11, 2000
    Date of Patent: December 11, 2001
    Assignee: Parker Hughes Institute
    Inventors: Fatih M. Uckun, Shyi-Tai M. Jan, Chen Mao
  • Patent number: 6258841
    Abstract: Novel tubulin binding compounds having potent tubulin depolymerization activity and inhibitory activity against tubulin polymerization. The compounds are effective agents for inhibiting cellular proliferation, for example, in cancer cells. The compounds are adapted to interact favorably with a novel tubulin binding pocket, which pocket is useful for screening of anti-tubulin, anti-proliferation, and anti-cancer drugs.
    Type: Grant
    Filed: June 29, 1999
    Date of Patent: July 10, 2001
    Assignee: Parker Hughes Institute
    Inventors: Fatih M. Uckun, Shyi-Tai M. Jan, Chen Mao